Extrapulmonary tuberculosis (EPTB) refers to tuberculosis infections that occur outside the lungs, affecting organs such as lymph nodes, pleura, genitourinary tract, bones, and meninges. Diagnosis and treatment of EPTB can be challenging due to its diverse manifestations and often requires a combination of clinical, radiological, and microbiological assessments.
Antitubercular therapy refers to the treatment regimen used to combat tuberculosis, primarily involving a combination of antibiotics to ensure the complete eradication of Mycobacterium tuberculosis and prevent drug resistance. The standard therapy often includes the use of isoniazid, rifampicin, ethambutol, and pyrazinamide over a period of six months or more, depending on the patient's response and the presence of drug-resistant strains.
Drug-resistant tuberculosis is a form of tuberculosis that does not respond to the standard treatments due to resistance to one or more of the primary anti-TB drugs. This poses a significant public health challenge as it requires longer, more complex, and often less effective treatment regimens, increasing the risk of transmission and mortality.
Breastfeeding contraindications are specific medical or situational factors that make breastfeeding unsafe or inadvisable for either the mother or the infant. Understanding these contraindications is essential for ensuring the health and safety of both parties involved in the breastfeeding process.
HIV and tuberculosis (TB) co-infection is a significant public health challenge because HIV weakens the immune system, increasing the risk of active TB in infected individuals, while TB can accelerate the progression of HIV. Effective management requires integrated treatment strategies that address both infections simultaneously to reduce morbidity and mortality rates.